Vir Biotechnology

VIR54

$9.25arrow_drop_down6.28%-$0.61

VIR54

$9.25

arrow_drop_down6.28%-$0.61

Performance History

Key Stats
Open	$9.75
Prev. Close	$9.87
EPS	-3.93
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	9.16	10.07
52 Week Range	7.12	13.09

Ratios







EPS	-3.93

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Vir Biotechnology (VIR)

Vir Biotechnology Inc (VIR) is a biotechnology company that focuses on developing innovative therapies to combat infectious diseases. With a strong emphasis on research and development, Vir Biotechnology is at the forefront of developing cutting-edge solutions to address global health challenges. The company's stock price history has shown steady growth over the years, reflecting investor confidence in its potential. VIR stock has consistently performed well, attracting the attention of both institutional and retail investors.

In addition to its impressive stock performance, Vir Biotechnology has also been making headlines with its groundbreaking research and development efforts. The company's commitment to advancing science and technology has positioned it as a leader in the biotech industry. Through its smart analysis, Vir Biotechnology seeks to uncover new insights and trends that can drive innovation and ultimately improve patient outcomes. This focus on smart analysis has allowed Vir Biotechnology to stay ahead of the competition and deliver value to its shareholders.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Headquarters: San Francisco
Employees: 576
Exchange: NASDAQ

Keep an eye on Vir Biotechnology

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Vir Biotechnology 's (VIR) price per share?

The current price per share for Vir Biotechnology (VIR) is $9.25. The stock has seen a price change of -$0.62 recently, indicating a -6.28% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Vir Biotechnology (VIR)?

For Vir Biotechnology (VIR), the 52-week high is $13.09, which is 41.51% from the current price. The 52-week low is $7.12, the current price is 29.92% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Vir Biotechnology (VIR) a growth stock?

Vir Biotechnology (VIR) has shown an average price growth of -3.67% over the past three years. It has received a score of 16 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Vir Biotechnology as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Vir Biotechnology (VIR) stock price performance year to date (YTD)?

As of the latest data, Vir Biotechnology (VIR) has a year-to-date price change of -11.99%. Over the past month, the stock has experienced a price change of 20.6%. Over the last three months, the change has been 9.21%. Over the past six months, the figure is -5.32%. Looking at a longer horizon, the five-year price change stands at -29.66%.

help

Is Vir Biotechnology (VIR) a profitable company?

Vir Biotechnology (VIR) has a net income of -$615.06M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 74.22% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -9.18K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $86.18M, although specific revenue growth data is currently not available. The gross profit is $63.96M. Operating income is noted at -$661M. Furthermore, the EBITDA is -$533.94M.

help

What is the market capitalization of Vir Biotechnology (VIR)?

Vir Biotechnology (VIR) has a market capitalization of $1.27B. The average daily trading volume is 9.31, indicating the stock's liquidity and investor engagement.